Search Results - "Arjona Ferreira, Juan C."
-
1
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy
Published in The New England journal of medicine (18-02-2021)“…In two international, randomized, double-blind, 24-week, phase 3 trials involving women with uterine fibroid–associated heavy menstrual bleeding, therapy with…”
Get full text
Journal Article -
2
Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial
Published in American journal of kidney diseases (01-04-2013)“…Background Treatment with oral antihyperglycemic agents has not been well characterized in patients with type 2 diabetes and end-stage renal disease (ESRD)…”
Get full text
Journal Article -
3
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)
Published in The Lancet (British edition) (18-06-2022)“…Endometriosis is a common cause of pelvic pain in women, for which current treatment options are suboptimal. Relugolix, an oral gonadotropin-releasing hormone…”
Get full text
Journal Article -
4
Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study
Published in Pain (Amsterdam) (01-05-2018)“…The long-term safety of naldemedine, a peripherally acting µ-opioid receptor antagonist, was evaluated in patients with opioid-induced constipation and chronic…”
Get full text
Journal Article -
5
Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study
Published in Human reproduction (Oxford) (01-03-2024)“…Abstract STUDY QUESTION What is the efficacy and safety of long-term treatment (up to 2 years) with relugolix combination therapy (CT) in women with moderate…”
Get full text
Journal Article -
6
Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis
Published in F&S Reports (Online) (01-06-2023)“…Treatment of uterine fibroids (UF) and endometriosis (EM) has relied on the surgical skills of gynecologists to improve symptoms and potentially alter the…”
Get full text
Journal Article -
7
A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies
Published in Pain management (01-04-2023)“…This is a summary of research studies (known as clinical trials) called LIBERTY 1 and LIBERTY 2. The LIBERTY 1 and LIBERTY 2 studies looked at how well a…”
Get full text
Journal Article -
8
A Plain Language Summary to learn about relugolix combination therapy for the treatment of pain associated with endometriosis
Published in Pain management (London) (01-11-2023)Get full text
Journal Article -
9
Treatment of uterine fibroid symptoms with relugolix combination therapy
Published in Reproductive health of woman (Online) (31-05-2024)“…Uterine fibroids are a common cause of heavy menstrual bleeding and pain. Treatment with the combination of relugolix (an oral gonadotropin-releasing…”
Get full text
Journal Article -
10
Treatment of Uterine Fibroid Symptoms With Relugolix Combination Therapy
Published in Obstetrical & gynecological survey (01-06-2021)“…(Abstracted from N Engl J Med 2021;384:630–642) Approximately 25% of women with uterine fibroids experience symptoms, most commonly heavy menstrual bleeding…”
Get full text
Journal Article